SUNSHINE BIOPHARMA INC's ticker is and the CUSIP is 867781403. A total of 12 filers reported holding SUNSHINE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,275 | -37.1% | 20,179 | 0.0% | 0.00% | – |
Q2 2023 | $9,978 | -29.4% | 20,179 | 0.0% | 0.00% | – |
Q1 2023 | $14,127 | +117625.0% | 20,179 | 0.0% | 0.00% | – |
Q4 2022 | $12 | -99.9% | 20,179 | 0.0% | 0.00% | – |
Q3 2022 | $15,000 | -28.6% | 20,179 | 0.0% | 0.00% | – |
Q2 2022 | $21,000 | -57.1% | 20,179 | 0.0% | 0.00% | – |
Q1 2022 | $49,000 | – | 20,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,100 | $183,104 | 0.01% |
Virtu Financial LLC | 36,660 | $23 | 0.00% |
BANK OF AMERICA CORP /DE/ | 13,872 | $8,878 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 20,179 | $12 | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 6,042 | $3,867 | 0.00% |
BANK OF MONTREAL /CAN/ | 30,000 | $21,600 | 0.00% |
New England Capital Financial Advisors LLC | 500 | $490 | 0.00% |
UBS Group AG | 7,210 | $4,615 | 0.00% |
OSAIC HOLDINGS, INC. | 6,628 | $4,000 | 0.00% |